1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one
C15H26O11 — CID 70658823
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one
1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one (PubChem CID 70658823) has the molecular formula C15H26O11 and a molecular weight of 382.36 g/mol. Its IUPAC name is 1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one.
Molecular Properties
| Compound Name | 1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one |
|---|---|
| PubChem CID | 70658823 |
| Molecular Formula | C15H26O11 |
| Molecular Weight | 382.36 g/mol |
| Exact Mass | 382.15 |
| IUPAC Name | 1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]propan-2-one |
| SMILES | CC(=O)CC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O |
| InChI | InChI=1S/C15H26O11/c1-5(18)2-6-9(19)12(22)14(8(4-17)24-6)26-15-13(23)11(21)10(20)7(3-16)25-15/h6-17,19-23H,2-4H2,1H3 |
| InChIKey | CZPVHXTZZCIQGE-UHFFFAOYSA-N |
| XLogP | -4.37 |
| TPSA | 186.37 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.36 |
| LogP ≤ 5 | -4.37 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70658823 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.